A5004495946- Inflammatory Bowel Disease
- SARS-CoV-2 and COVID-19 Research
- Liver Disease Diagnosis and Treatment
- Colorectal Cancer Screening and Detection
- Gastric Cancer Management and Outcomes
- Helicobacter pylori-related gastroenterology studies
- Hepatitis C virus research
- Autoimmune and Inflammatory Disorders
- Medical Research and Treatments
- Spinal Fractures and Fixation Techniques
- Genetic factors in colorectal cancer
- Spine and Intervertebral Disc Pathology
- Radiation Dose and Imaging
- Multiple and Secondary Primary Cancers
- Medical Imaging and Pathology Studies
- Dental Implant Techniques and Outcomes
- Pelvic and Acetabular Injuries
- Eosinophilic Esophagitis
- Vaccine Coverage and Hesitancy
- COVID-19 and healthcare impacts
- Ecology and Conservation Studies
- Occupational and environmental lung diseases
- Gastrointestinal disorders and treatments
- Hepatitis B Virus Studies
- Dental Radiography and Imaging
Yonsei University
2021-2024
Severance Hospital
2023-2024
ABSTRACT Background Many patients with colorectal polyposis demonstrate negative results in germline mutation test. This study aimed to uncover genetic variants associated nonhereditary using a genome‐wide association (GWAS). Methods At single referral university hospital, between January 2012 and September 2021, 638 ≥ 10 biopsy‐proven cumulative polyps on colonoscopy without mutations related hereditary cancer or were included. The control group comprised 1863 individuals from the Korea...
CAGE-B and SAGE-B scores, consisting of age fibrotic burden as cirrhosis and/or liver stiffness, were recently proposed to predict hepatocellular carcinoma (HCC) risk among Caucasian chronic hepatitis B (CHB) patients undergoing long-term antiviral therapy. We externally validated their predictive performances an independent cohort from Asia, compared other conventional prediction models. consecutively recruited CHB with well-controlled viremia (serum HBV DNA < 2000 IU/mL) receiving Patients...
The impact of vaccination on inflammatory bowel disease (IBD) patients is still unknown, and no studies have assessed the changes in patient-reported outcomes (PROs) after with IBD. Therefore, this study, we investigated vaccines PROs
Background: Notably, 5-aminosalicylates (5-ASA) are vital in treating inflammatory bowel diseases (IBD). The adverse events of 5-ASA rarely occur but they could be fatal. Objectives: We aimed to discover new genetic biomarkers predicting 5-ASA-induced patients with IBD. Design: This was a retrospective observational study. Methods: performed genome-wide association study on IBD South Korea. defined subset 1 as 39 all and 272 controls; 2 20 severe 291 controls (mild control); 3 4 19 mild...